Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $69.6600 (-1.37%) ($69.2300 - $70.4200) on Tue. Jan. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.02% (three month average) | RSI | 66 | Latest Price | $69.6600(-1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 1% a day on average for past five trading days. | Weekly Trend | BAX advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(56%) SPLV(52%) VYM(51%) XLP(51%) DIA(48%) | Factors Impacting BAX price | BAX will decline at least -1.01% in a week (0% probabilities). TLT(-19%) XHB(-9%) VIXM(-9%) VXX(-8%) UUP(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.01% (StdDev 2.02%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $69.04(0.9%) | 10 Day Moving Average | $67.94(2.53%) | 20 Day Moving Average | $66.43(4.86%) | To recent high | -1.4% | To recent low | 13.4% | Market Cap | $35.539b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |